CELZ Stock — Creative Medical Technology Holdings Inc.: Cash, EV, Pipeline

Share price

$0.97

Market cap

$6.4M

Cash

$8.7M

Enterprise value

-$2.3M

Balance sheet

Cash	$8.7M
Debt	$0.0M
Net cash	$8.7M
Enterprise value	-$2.3M
Basic shares	6.5M shares
Fully diluted shares	12.7M shares
Fully diluted market cap	$12.3M
Cash per share	$1.34

Cash figures as of 2026-06-30. Database snapshot: 2026-09-21.

Price history

Loading CELZ daily closes…

Loading price history…

Upcoming catalysts

Expected	Drug	Phase	Indication	Mgmt guide
Mar 3 - Apr 14	CELZ-201-DDT	Phase 2	Chronic Low-back Pain; Degenerative Disc Disease	—
Mar 14 - Apr 25	CELZ-201 Administration	Phase 2	Type 1 Diabetes; Diabetes Mellitus, Type 1	—

Estimated readout windows: registry primary-completion date + 6-12 weeks. Windows already open are shown from "Now". Drug names link to ClinicalTrials.gov.

Full readout calendar →

Pipeline assets

CELZ-201

Phase 2 · Active Modality: cell therapy

Aliases AlloStem, Olastrocel

Indications

Chronic lower back pain due to degenerative disc disease (Phase 2)
New onset Type 1 diabetes (Phase 2)

Status note Two FDA-cleared Phase 1/2 trials in progress: ADAPT (Olastrocel) for chronic lower back pain due to degenerative disc disease, a randomized Phase 1/2 study with FDA Fast Track designation; CREATE 1 for new onset Type 1 diabetes. Near-term priorities include completing ADAPT expanded-cohort enrollment and Phase 3 planning interactions.

Per-asset detail extracted from the 10-Q filed 2026-08-07. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.

Pipeline

Lead drug	CELZ-201-DDT
Lead indication	Chronic Low-back Pain
Lead phase	Phase 2
Active trials	3

Active clinical trials

Trial	Phase	Status	Role	Sponsor	BP	Condition(s)	Mgmt guide
NCT06053242	Phase 2	Active, not recruiting	Sponsor	CELZ	—	Chronic Low-back Pain; Degenerative Disc Disease	—
NCT05626712	Phase 2	Recruiting	Sponsor	CELZ	—	Type 1 Diabetes; Diabetes Mellitus, Type 1	—
NCT07562243	Not disclosed	Not yet recruiting	Sponsor	CELZ	—	Burn Pit Exposure; Airborne Hazard Exposure; Veteran Health	—

Sponsor-matched active trials from ClinicalTrials.gov (3 as sponsor, 0 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.

View all 3 active trials for Creative Medical Technology Holdings Inc on ClinicalTrials.gov

No specialist-fund holders in 13F data for this company.

CELZ — Creative Medical Technology Holdings Inc.